Page 60 - Michael Erman News Today

(Reuters) - The director of the U.S. Centers for Disease Control and Prevention (CDC) signed off on the U.S. Food and Drug Administration's full appro...

Drugmaker Bristol Myers Squibb Co on Friday posted slightly better than expected fourth-quarter earnings on strong sales of blood thinner Eliquis and cancer drug Opdivo....

In an unusual move, the U.S. Food and Drug Administration (FDA) urged Pfizer and BioNTech to apply for authorization of the first COVID-19 vaccine for children under the age of five.

By Michael Erman (Reuters) - Merck & Co said on Wednesday it expects its 2022 sales to increase as much as 18 percent over last year, mostly on sales ...

(Reuters) -The U.S. Food and Drug Administration on Monday gave full approval to Moderna Incs COVID-19 vaccine for people age 18 and older, making it the second fully approved vaccine

Merck & Cos new antiviral pill, once touted as a potential game changer for treating COVID-19, is the last choice among four available options for at-risk patients given its relatively low... | January 31, 2022

By Deena Beasley (Reuters) - Merck & Co's new antiviral pill, once touted as a potential game changer for treating COVID-19, is the last choice among ...

By Michael Erman and Ludwig Burger

By Michael Erman NEW YORK (Reuters) - Pfizer Inc and BioNTech SE said on Tuesday they started a clinical trial to test a new version of their vaccine ...

By Michael Erman NEW YORK (Reuters) - An influential consumer advocacy group is pressing Pfizer Inc to supply more of its new COVID-19 pill Paxlovid t...